These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 8191825

  • 21. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
    Trerè D, Melchiorri C, Chieco P, Marabini A, Derenzini M.
    Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
    [Abstract] [Full Text] [Related]

  • 22. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT, Gentile P, Tarectecan A, Fuchs A.
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [Abstract] [Full Text] [Related]

  • 23. AgNORs in lung cancer: correlation with DNA ploidy and degree of differentiation.
    Lee YC, Chern JH, Li WY, Huang MH, Perng RP.
    Anal Quant Cytol Histol; 1997 Jun; 19(3):271-6. PubMed ID: 9196811
    [Abstract] [Full Text] [Related]

  • 24. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
    Pomjanski N, Motherby H, Buckstegge B, Knops K, Rohn BL, Böcking A.
    Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
    [Abstract] [Full Text] [Related]

  • 25. Manual and automated AgNOR count in differentiating reactive mesothelial from metastatic malignant cells in serous effusions.
    Mohanty SK, Dey P, Rana P.
    Anal Quant Cytol Histol; 2003 Oct; 25(5):273-6. PubMed ID: 14603724
    [Abstract] [Full Text] [Related]

  • 26. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY, Rong TH, Liang YR, Long H, Chen QL, Ma GW.
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [Abstract] [Full Text] [Related]

  • 27. Evaluation of significance of AgNOR counts in differentiating benign from malignant lesions in the breast.
    Dube MK, Govil A.
    Indian J Pathol Microbiol; 1995 Jan; 38(1):5-10. PubMed ID: 8919463
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Silver staining nucleolar organiser region (AgNOR) study in melanocytic skin tumours.
    Naik R, Raghuveer CV, Jacob DL.
    J Indian Med Assoc; 1997 Jul; 95(7):420-1. PubMed ID: 9425842
    [Abstract] [Full Text] [Related]

  • 31. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG, Banerjee D, Harris P, Gibson S, McFadden RG.
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A study of the utility of silver nucleolar organizer regions in categorization and prognosis of salivary gland tumors.
    Adeyemi BF, Kolude BM, Akang EE, Lawoyin JO.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Oct; 102(4):513-20. PubMed ID: 16997120
    [Abstract] [Full Text] [Related]

  • 35. Distribution of silver-stained interphase nucleolar organizer regions as a parameter to distinguish neoplastic from nonneoplastic reactive cells in human effusions.
    Derenzini M, Nardi F, Farabegoli F, Ottinetti A, Roncaroli F, Bussolati G.
    Acta Cytol; 1989 Oct; 33(4):491-8. PubMed ID: 2473585
    [Abstract] [Full Text] [Related]

  • 36. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity.
    Xie X, Clausen OP, Sudbö J, Boysen M.
    Cancer; 1997 Jun 01; 79(11):2200-8. PubMed ID: 9179068
    [Abstract] [Full Text] [Related]

  • 37. A new epithelial membrane antigen (Calam 27) as a marker of carcinoma in serous effusions.
    Gioanni J, Caldani C, Zanghellini E, Mazeau C, Duplay H, Ferrua B, Schneider M.
    Acta Cytol; 1991 Jun 01; 35(3):315-9. PubMed ID: 2042433
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.